An outcome measure in schizophrenia: Mortality

Canadian Journal of Psychiatry

Volumn 52, Issue 1, 2007, Pages 55-60

  Seeman, Mary V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antipsychotics; Family support; Mortality; Schizophrenia

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE; ZOTEPINE;

CARDIOVASCULAR RISK; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIA; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; LIFESTYLE MODIFICATION; LONG QT SYNDROME; MENTAL HEALTH CARE; MORTALITY; REVIEW; SCHIZOPHRENIA; SIDE EFFECT; SUDDEN DEATH; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 34248363992     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370705200109     Document Type: Review

References (52)

1. Shorter E. A History of psychiatry: from the era of the asylum to the age of Prozac. Toronto (ON): John Wiley & Sons; 1998.
2. Honigfeld G, Gillis RD, Klett CJ. Nurses' Observation Scale for Inpatient Evaluation: a new scale for measuring improvement in chronic schizophrenia. J Clin Psychol. 1965;21:65-71.
3. Swayze VW, 2nd. Frontal leukotomy and related psychosurgical procedures in the era before antipsychotics (1935-1954): a historical overview. Am J Psychiatry. 1995;152(4):505-515.
4. Clark DH. The story of a mental hospital: Fulbourn, 1858-1983 [Internet] [updated 28 May 2005; cited 18 June 2006]. Available from: http://human-nature. com/free-associations/clark/chap2.html
5. Menninger W. Psychiatry in a troubled world. New York (NY): MacMillan; 1948.
6. Goffman E. Asylums. Essays on the social situation of mental patients and other inmates. New York (NY): Doubleday Anchor; 1961.
7. White MC, Chafetz L, Collins-Bride G, et al. History of arrest, incarceration and victimization in community-based severely mentally ill. J Community Health. 2006;31(2):123-135.
8. Ettner SL, Frank R, Kessler RC. The impact of psychiatric disorders on labor market outcomes. Industrial and Labor Relations Review. 1997;51(1):64-81.
9. Mittal D, Davis CE, Depp C, et al. Correlates of health-related quality of well-being in older patients with schizophrenia. J Nerv Ment Dis. 2006;194(5):335-340.
10. Lieberman JA, Stroup TS, McEvoy JP, et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209-1223.
11. Drew LR. Mortality and mental illness. Aust N Z J Psychiatry. 2005;39(3):194-197.
12. Filik R, Sipos A, Kehoe PG, et al. The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand. 2006;113(4):298-305.
13. Goff DC, Sullivan LM, McEvoy JP, et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005;80(1):45-53.
14. Daumit GL, Pronovost PJ, Anthony CB, et al. Adverse events during medical and surgical hospitalizations for persons with schizophrenia. Arch Gen Psychiatry. 2006;63(3):267-272.
15. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000;177:212-217.
16. Hennekens CH, Hennekens AR, Hollar D, et al. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150(5):1115-1121.
17. Rasanen S, Hakko H, Viilo K, et al. Excess mortality among long-stay psychiatric patients in Northern Finland. Soc Psychiatry Psychiatr Epidemiol. 2003;38(6):297-304.
18. Prior P, Hassall C, Cross KW. Causes of death associated with psychiatric illness. J Public Health Med. 1996;18(4):381-389.
19. Saku M, Tokudome S, Ikeda M, et al. Mortality in psychiatric patients, with a specific focus on cancer mortality associated with schizophrenia. Int J Epidemiol. 1995;24(2):366-372.
20. Walsh E, Moran P, Scott C, et al. Prevalence of violent victimisation in severe mental illness. Br J Psychiatry. 2003;183:233-238.
21. Hiroeh U, Appleby L, Mortensen PB, et al. Death by homicide, suicide, and other unnatural causes in people with mental illness: a population-based study. Lancet. 2001;358(9299):2110-2112.
22. Healy D, Harris M, Tranter R, et al Lifetime suicide rates in treated schizophrenia: 1875-1924 and 1994-1998 cohorts compared. Br J Psychiatry. 2006;188:223-228.
23. Lawrence D, Jablensky AV, Holman CD, et al. Mortality in Western Australian psychiatric patients. Soc Psychiatry Psychiatr Epidemiol. 2000;35(8):341-347.
24. Amaddeo F, Bisoffi G, Bonizzato P, et al. Mortality among patients with psychiatric illness. A ten-year case register study in an area with a community-based system of care. Br J Psychiatry. 1995;166:783-788.
25. Hansen V, Jacobsen BK, Arnesen E. Cause-specific mortality in psychiatric patients after deinstitutionalisation. Br J Psychiatry. 2001;179:438-443.
26. Lerman P, Apgar DH, Jordan T. Deinstitutionalization and mortality: findings of a controlled research design in New Jersey. Ment Retard. 2003;41(4):225-236.
27. Stark C, MacLeod M, Hall D, et al. Mortality after discharge from long-term psychiatric care in Scotland, 1977-94: a retrospective cohort study. BMC Public Health [Internet]. 2003;3:30 [cited 2006 Oct 3]; Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid= 12962551
28. Hibbs JR, Benner L, Klugman L, et al. Mortality in a cohort of homeless adults in Philadelphia. N Engl J Med. 1994;331(5):304-309.
29. Babidge NC, Buhrich N, Butler T. Mortality among homeless people with schizophrenia in Sydney, Australia: a 10-year follow-up. Acta Psychiatr Scand. 2001;103(2):105-110.
30. Heila H, Haukka J, Suvisaari J, et al. Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med. 2005;35(5):725-732.
31. Salokangas RK, Honkonen T, Stengard E, et al. Mortality in chronic schizophrenia during decreasing number of psychiatric beds in Finland. Schizophr Res. 2002;54(3):265-275.
32. Bralet MC, Yon V, Loas G, Noisette C. Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients] Encephale. 2000;26(6):32-41.
33. Dembling BP, Chen DT, Vachon L. Life expectancy and causes of death in a population treated for serious mental illness. Psychiatr Serv. 1999;50(8):1036-1042.
34. Joukamaa M, Heliovaara M, Knekt P, et al Schizophrenia, neuroleptic medication and mortality. Br J Psychiatry. 2006;188:122-127.
35. Saari K, Koponen H, Laitinen J, et al. Hyperlipidemia in persons using antipsychotic medication: a general population-based birth cohort study. J Clin Psychiatry. 2004;65(4):547-550.
36. Osborn DP, Nazareth I, King MB. Risk for coronary heart disease in people with severe mental illness: Cross-sectional comparative study in primary care. Br J Psychiatry. 2006;188:271-277.
37. Hagg S, Lindblom Y, Mjorndal T, et al. High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia. Int Clin Psychopharmacol. 2006;21(2):93-8.
38. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294(15):1934-1943.
39. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005;353(22):2335-2341.
40. Ollendorf DA, Joyce AT, Rucker M. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia. MedGenMed [Internet]. 2004;6(1):5 [cited 2006 Oct 3]; Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool= pubmed&pubmedid=15208518
41. Basu A, Meltzer HY. Differential trends in prevalence of diabetes and unrelated general medical illness for schizophrenia patients before and after the atypical antipsychotic era. Schizophr Res. 2006;86(1-3):99-109.
42. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19(Suppl 1):1-93.
43. Sernyak MJ, Gulanski B, Rosenheck R. Undiagnosed hyperglycemia in patients treated with atypical antipsychotics. J Clin Psychiatry. 2005;66(11):1463-1467.
44. Ray WA, Meredith S, Thapa PB, et al. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry. 2001;58(12):1161-1167.
45. Straus SM, Sturkenboom MC, Bleumink GS, et al. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J. 2005;26(17):2007-2012.
46. Martin MA. The homeless mentally ill and community-based care: changing a mindset. Community Ment Health J. 1990;26(5):435-447.
47. Doornbos MM. Family caregivers and the mental health care system: reality and dreams. Arch Psychiatr Nurs. 2002;16(1):39-46.
48. Smith GC. Patterns and predictors of service use and unmet needs among aging families of adults with severe mental illness. Psychiatr Serv. 2003;54(6):871-877.
49. Piat M, Ricard N, Lesage A, et al. Le point de vue des responsables des ressources de type familial sur les transformations des services de santé mentale au Québec. Santé Mentale Québec. 2005;30:209-231.
50. Bayer R, Fairchild AL. The genesis of public health ethics. Bioethics. 2004;18(6):473-492.
51. Gross ML. Autonomy and paternalism in communitarian society. Patient rights in Israel. Hastings Cent Rep. 1999;29(4):13-20.
52. Loewy EH. In defense of paternalism. Theor Med Bioeth. 2005;26(6):445-468.